Novel risk factors for Clostridium difficile- associated disease in a setting of endemicity?

Clinical Infectious Diseases

Volumn 47, Issue 3, 2008, Pages 429-430

  Goorhuis, Abraham ^a   Van Dissel, Jaap T ^a   Kuijper, Ed J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PROTON PUMP INHIBITOR; VANCOMYCIN;

ARTIFICIAL VENTILATION; BACTERIAL INFECTION; CLOSTRIDIUM DIFFICILE; COHORT ANALYSIS; DIARRHEA; ENDEMIC DISEASE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INCIDENCE; LETTER; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR;

CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; DISEASE OUTBREAKS; ENDEMIC DISEASES; HUMANS; RISK FACTORS; SELECTION BIAS;

EID: 47549097000     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/589928     Document Type: Letter

References (3)

1. Dubberke ER, Reske KA, Yan Y, Olsen MA, McDonald LC, Fraser VJ. Clostridium difficile-associated disease in a setting of endemicity: identification of novel risk factors. Clin Infect Dis 2007; 45:1543-9.
2. Paltansing S, van den Berg RJ, Guseinova RA, Visser CE, van der Vorm ER, Kuijper EJ. Characteristics and incidence of Clostridium difficile-associated disease in The Netherlands, 2005. Clin Microbiol Infect 2007; 13:1058-64.
3. Kuijper EJ, van den Berg RJ, Debast S, et al. Clostridium difficile ribotype 027, toxinotype III, the Netherlands. Emerg Infect Dis 2006; 12:827-30.